SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe

← ETF Screener

XDNA.TO iShares Genomics Immunology and Healthcare Index ETF CAD

Issuer
IShares
Inception
Apr 26, 2022
AUM
C$16.5M
Expense ratio
0.44%
Yield
—
Asset class
Equity
Holdings
50
Last price
C$54.82

The fund holds a concentrated portfolio of global companies in the biopharmaceutical and healthcare equipment and services industries that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering. In addition to these industry screens, companies must also meet certain size and liquidity measures for index eligibility. The underlying index then assigns a Relationship Keyword Score to each of the eligible companies using the FactSet Supply Chain Relationships database in search for keywords related to Genomics and Immuno Biopharmaceutical products and technologies. The top 50 names with the highest scores are included in the index. Holdings are weighted by market-cap and are constrained such that no individual security exceeds 4% weight of the portfolio. The index rebalances semi-annually.

+40.4%
2025-11-24low 36.99 · high 63.642026-11-20

Performance

1M3MYTD1Y3Y ann.5Y ann.
XDNA.TO-11.5%-4.2%+47.2%+45.9%+24.0%—
Equity average (1460 funds)-5.4%-4.7%+1.4%+3.9%+11.9%+4.6%

Insider activity in the holdings

Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$15K net.

HoldingWeightInsiders boughtInsiders sold
KURA KURA ONCOLOGY0.61%$4.2M$1.9M
CRVS CORVUS PHARMACEUTICALS0.61%$50K$0

Holdings · as of Nov 20, 2026

#HoldingWeight
1MRNA MODERNA13.00%
2GMAB.CO GENMAB6.45%
3TWST TWIST BIOSCIENCE4.99%
4REGN REGENERON PHARMACEUTICALS4.50%
5BAYN.DE BAYER AG4.44%
64502.T TAKEDA PHARMACEUTICAL4.40%
7EXEL EXELIXIS INC3.86%
8VRTX VERTEX PHARMACEUTICALS3.61%
9ROP.SW ROCHE PS PAR AG3.55%
10INCY INCYTE CORP3.50%
11MRK MERCK & CO INC3.40%
12RVMD REVOLUTION MEDICINES3.30%
13SAN.PA SANOFI SA3.16%
14IPN.PA IPSEN SA3.03%
15XDNA.TO BIONTECH SE ADR2.86%
16GSK.L GLAXOSMITHKLINE2.86%
17IOVA IOVANCE BIOTHERAPEUTICS INC2.75%
18IBRX IMMUNITYBIO2.40%
19CAI CARIS LIFE SCIENCES2.21%
20IDYA IDEAYA BIOSCIENCES2.11%
214528.T ONO PHARMACEUTICAL1.72%
22RCUS ARCUS BIOSCIENCES1.28%
23NVAX NOVAVAX1.17%
24VIR VIR BIOTECHNOLOGY1.15%
25CRSP CRISPR THERAPEUTICS AG1.08%
26NUVB NUVATION BIO CLASS A0.91%
27PSNL PERSONALIS0.89%
28XNCR XENCOR0.74%
296887.HK SUNSHINE LAKE PHARMA LTD CLASS H0.74%
30RIGL RIGEL PHARMACEUTICALS0.71%
31KURA KURA ONCOLOGY0.61%
32CRVS CORVUS PHARMACEUTICALS0.61%
33JANX JANUX THERAPEUTICS0.57%
34VSTM VERASTEM INC0.54%
35PACB PACIFIC BIOSCIENCES OF CALIFORNIA0.49%
362595.HK GENFLEET THERAPEUTICS (SHANGHAI) I0.44%
37VLA.PA VALNEVA0.42%
38NTLA INTELLIA THERAPEUTICS0.39%
39DNA GINKGO BIOWORKS HOLDINGS CLASS A0.37%
402696.HK SHANGHAI HENLIUS BIOTECH H0.35%
41CTMX CYTOMX THERAPEUTICS0.34%
42DSGN DESIGN THERAPEUTICS0.34%
43OCGN OCUGEN0.24%
44PRME PRIME MEDICINE0.11%

Sector breakdown

Healthcare100.0%

Country breakdown

United States61.5%
Germany7.3%
France6.6%
Denmark6.3%
Japan6.0%
Switzerland4.6%
United Kingdom2.9%
Canada2.5%
China1.5%
Iceland0.5%
Other0.3%

Distributions

No distributions on file.

Members of Congress who disclosed this ETF

No member of Congress has disclosed a trade in XDNA.TO in the filings we hold.

Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 22, 2026. This is historical data, not investment advice. Report a data error

XDNA.TO: iShares Genomics Immunology and Healthcare Index ETF CAD — Holdings, Performance and Insider Activity | InsiderBuying.com